Defendant drug companies in the Xarelto mass tort want to know how the plaintiffs are funding their lawsuits.

Bayer and Janssen Pharmaceuticals filed a motion late last week requesting that the Philadelphia Court of Common Pleas compel discovery on the topic of third-party litigation funding.